Health Canada announced July 31 that it would be changing the
labelling requirements for certain homeopathic remedies, and would
no longer be permitting certain previously allowed claims.
Nosodes, homeopathic preparations intended to prevent particular
diseases, are now required to bear a contra-indication statement
specifically indicating that the product is not a vaccine, and is
not an alternative to vaccination. Further, nosode labels must
state that the product has not been proven to prevent infection,
and that Health Canada does recommend its use in children.
In addition, Health Canada has indicated that it will no longer
permit direct or indirect claims that homeopathic remedies may
relieve cold, cough, or flu symptoms on products that are indicated
for use by children 12 years old or younger unless the claim is
supported by scientific evidence. This is a major change in the
evidence requirement for this class of homeopathic product, other
homeopathic remedies can make a specific use claim if it is
supported by published homeopathic references.
Licence holders have been asked to comply with the labeling
change for nosodes by January 2016, while the changes for
children's cough, cold, and flu remedies must be implemented by
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
The prospect of an internal investigation raises many thorny issues. This presentation will canvass some of the potential triggering events, and discuss how to structure an investigation, retain forensic assistance and manage the inevitable ethical issues that will arise.
From the boardroom to the shop floor, effective organizations recognize the value of having a diverse workplace. This presentation will explore effective strategies to promote diversity, defeat bias and encourage a broader community outlook.
Staying local but going global presents its challenges. Gowling WLG lawyers offer an international roundtable on doing business in the U.K., France, Germany, China and Russia. This three-hour session will videoconference in lawyers from around the world to discuss business and intellectual property hurdles.
Effective September 1, 2016, the Disposition of Surplus Real Property Regulation to the Ontario Education Act was amended with the intention to reduce barriers to the formation of health and community hubs in Ontario.
This appeal relates to two generic drug submissions for two different products: exemestane and infliximab. Both submissions cross-referenced the submission of another generic company that had received a Notice of Compliance.
Two recent decisions from the Supreme Court of Canada directly affect Quebec's farm businesses by confirming La Financière Agricole du Québec's discretion in the administration of the farm income stabilization program...
On October 6, 2016, the Ontario Legislature reintroduced the Patients First Act, 2016 as Bill 41. Bill 41 is very similar to its predecessor, Bill 210, which was introduced in June 2016, but makes some important changes to the previous bill.
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).